South Korea Weighs Earlier End-of-Life Treatment Withdrawal Amid Dignity Debate
Translated from Korean, summarized and contextualized by DistantNews.
At a glance
- South Korea is considering advancing the timing for discontinuing life-sustaining treatment from the 'imminent death' stage to the 'terminal' stage.
- The current law distinguishes between 'imminent death' and 'terminal' illness, but the clinical boundary is often unclear.
- This change aims to address the gap between the law and clinical practice, but raises concerns about the societal acceptance of death as a choice.
South Korea is contemplating a significant shift in its end-of-life care policy, proposing to advance the timing for discontinuing life-sustaining treatment. The government is considering moving the trigger point from the current 'imminent death' stage to a broader 'terminal' stage. This adjustment seeks to reconcile the legal framework with clinical realities, as the distinction between these two stages is often medically ambiguous. Doctors currently interpret the 'imminent death' clause strictly, leading to only about 20% of individuals with advance directives successfully having their end-of-life treatment withdrawn. The proposed change aims to make the law more practical and ensure that patients' wishes for end-of-life care can be more effectively honored. However, the move also sparks concern in a society where discussing death has long been taboo, as it accelerates the acceptance of death as a personal choice. The debate highlights a tension between respecting individual autonomy in dying and societal comfort levels with end-of-life decisions.
Originally published by Dong-A Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.